High mobility group box 1 protein: Possible pathogenic link to atrial fibrillation

Chinese Medical Journal

Volumn 125, Issue 13, 2012, Pages 2346-2348

  Hu, Xiao rong ^a   Wang, Xiao hong ^a   Liu, Hua fen ^a   Zhou, Wen jie ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Atrial fibrillation; High mobility group box 1 protein; Inflammation; Matrix metalloproteinase; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ATRIAL FIBRILLATION; HMGB1 PROTEIN; HUMANS; METALLOENDOPEPTIDASES; OXIDATIVE STRESS;

EID: 84863797956     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.13.019     Document Type: Article

References (31)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982; 306: 1018-1022.
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001; 285: 2370-2375.
3. Hoit BD. Matrix metallproteinases and atrial structural remodeling. J Am Coll Cardiol 2003; 42: 345-347.
4. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initation and perpetuation of atrial fibrillation. J Am Coll Cardiol 2007; 50: 2021-2028.
5. Tousoulis D, Zisimos K, Antoniades C, Stefanadi E, Siasos G, Tsioufis C, et al. Oxidative stress and inflammayory process in patients with atrial fibrillation: the role of left atrium distension. Int J Cardiol 2009; 136: 258-262.
6. Salman S, Bajwa, Gajic O, Afessa B. Paroxysmal atrial fibrillation in critically ill patients with sepsis. J Intensive Care Med 2008; 23: 178-183.
7. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-251.
8. Hu X, Zhou W, Bai Q, Wang J, Yang X, Xu C, et al. Increased serum high mobility group box 1 protein in patients with atrial fibrillation. Biomed Aging Pathol 2011; 1: 52-55.
9. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
10. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5: 331-342.
11. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008; 117: 3216-3226.
12. Hu X, Jiang H, Bai Q, Zhou X, Xu C, Lu Z, et al. Increased serum HMGB1 is related to the severity of coronary artery stenosis. Clin Chim Acta 2009; 406: 139-142.
13. Hu X, Zhou X, He B, Xu C, Wu L, Cui B, et al. Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Eur J Pharmacol 2010; 638: 84-89.
14. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192: 565-570.
15. Li W, Sama AE, Wang H. Role of HMGB1 in cardiovascular diseases. Curr Opin Pharmacol 2006; 6: 130-135.
16. Liu J, Fang PH, Dibs S, Hou Y, Li XF, Zhang S. High-sensitivity C-reactive protein as a predictor of AF recurrence after primary circumferential pulmonary vein isolation. Pacing Clin Electrophysiol 2010; 34: 398-406.
17. Kawahara K, Biswas KK, Unoshima M, Ito T, Kikuchi K, Morimoto Y, et al. C-reactive protein induces high mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells. Cardiovasc Pathol 2008; 17: 129-138.
18. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001; 104: 174-180.
19. Gong YT, Li WM, Li Y, Yang SS, Sheng L, Yang N, et al. Probucol attenuates atrial autonomic remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Chin Med J 2009; 122: 74-82.
20. Tang D, Shi Y, Kang R, Li T, Xiao W, Wang H, et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 2007; 81: 741-747.
21. Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, et al. HMGB1 release induced by liver ischmia involves toll-like receptor 4-depedent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007; 204: 2913-2923.
22. Zhang ZW, Zhang QY, Zhou MT, Liu NX, Chen TK, Zhu YF, et al. Antioxidant inhibits HMGB1 expression and reduces pancreas injury in rats with severe acute pancreatitis. Dig Dis Sci 2010; 55: 2529-2536.
23. Yasuda T, Ueda T, Takeyama Y, Shinzeki M, Sawa H, Nakajima T, et al. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas 2006; 33: 359-363.
24. Kourliouros A, Savelieva I, Kiotsekoglou A, Jahangiri M, Camm J. Current concepts in the pathogenesis of atrial fibrillation. Am Heart J 2009; 157: 243-252.
25. Nakano Y, Niida S, Dote K, Takenaka S, Hirao H, Miura F, et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol 2004; 43: 818-825.
26. Chen CL, Huang SK, Lin JL, Lai LP, Lai SC, Liu CW, et al. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation. J Mol Cell Cardiol 2008; 45: 742-753.
27. Moe GW, Laurent G, Doumanovskaia L, Konig A, Hu X, Dorian P. Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure. J Card Fail 2008; 14: 768-776.
28. Liu PL, Tsai JR, Hwang JJ, Chou SH, Cheng YJ, Lin FY, et al. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness. Am J Respir Cell Mol Biol 2010; 43: 530-538.
29. Qiu J, Xu J, Zheng Y, Wei Y, Zhu X, Lo EH, et al. High-mobility group box 1 promotes metalloproteinase-9 upregulation through toll-like receptor 4 after cerebral ischemia. Stroke 2010; 41: 2077-2082.
30. Kato T, Yamashita T, Sekiguchi A, Tsuneda T, Sagara K, Takamura M, et al. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat. J Cardiovasc Electrophysiol 2008; 19: 415-420.
31. Ichiki H, Orihara K, Hamasaki S, Ishida S, Oketani N, Iriki Y, et al. The role of infection in the development of non-valvular atrial fibrillation: up-regulate of toll-like receptor 2 expression levels on monocytes. J Cardiol 2009; 53: 127-135.